Clinical study of HSB-1940
Latest Information Update: 02 Feb 2024
At a glance
- Drugs HSB-1940 (Primary)
- Indications Cancer
- Focus Adverse reactions
Most Recent Events
- 15 Feb 2023 New trial record
- 13 Feb 2023 According to a Hillstream BioPharma media release, the company expect to initiate this trial in 2024.